Department of Internal Medicine, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.
Department of Radiology, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.
Medicine (Baltimore). 2022 Oct 14;101(41):e31072. doi: 10.1097/MD.0000000000031072.
Underwater endoscopic mucosal resection (UW-EMR) has been recently introduced as an effective technique for rectal third layer subepithelial tumors. Therefore, we aimed to assess the safety, efficacy, and procedure time of UW-EMR for upper gastrointestinal subepithelial tumors (SETs) originating from the deep mucosal and/or submucosal layers.
Between August 2018 to July 2022, a total of 17 SETs (7 duodenal SETs, 6 gastric SETs, and 4 esophageal SETs) were included in this study. On endoscopic ultrasound examinations, the tumors were found to be embedded in the submucosa without muscularis propria invasion. All SETs were resected successfully using UW-EMR. The characteristics of the tumors and their R0 resection rate, adverse event rate, and recurrence rate were evaluated retrospectively.
The mean tumor size was 0.9 cm (range, 0.3-1.5 cm). En bloc resection and complete resection rates were 100%, respectively. The patients showed no complications such as perforation or bleeding. Histologic assessments of the resected tumors revealed 9 neuroendocrine tumors (7 on the duodenum, 2 on the stomach), 2 gastric cystica profunda, 1 gastric follicular lymphoma, 1 gastric fibromyxoma, 3 esophageal granular cell tumors, and 1 esophageal adenoid cystic carcinoma. The mean procedural time was 3.2 min (range, 1.3-8.7 minutes). The overall en bloc and complete resection rates were 100%, respectively. No recurrence was observed during the follow-up period.
UW-EMR is a safe and effective treatment for upper gastrointestinal SETs embedded in the submucosal layer. Further studies are needed to compare other endoscopic resection techniques.
水下内镜黏膜切除术(UW-EMR)最近被引入作为直肠第三层黏膜下肿瘤的有效治疗方法。因此,我们旨在评估 UW-EMR 治疗起源于深层黏膜和/或黏膜下层的上消化道黏膜下肿瘤(SET)的安全性、疗效和手术时间。
2018 年 8 月至 2022 年 7 月,共有 17 个 SET(7 个十二指肠 SET、6 个胃 SET 和 4 个食管 SET)纳入本研究。在内镜超声检查中,发现肿瘤嵌入黏膜下层,无固有肌层侵犯。所有 SET 均成功采用 UW-EMR 切除。回顾性评估肿瘤特征及其 R0 切除率、不良事件发生率和复发率。
平均肿瘤大小为 0.9cm(范围,0.3-1.5cm)。整块切除率和完全切除率分别为 100%。患者无穿孔或出血等并发症。切除肿瘤的组织学评估显示 9 个神经内分泌肿瘤(7 个在十二指肠,2 个在胃)、2 个胃囊性深层、1 个胃滤泡性淋巴瘤、1 个胃纤维粘液瘤、3 个食管颗粒细胞瘤和 1 个食管腺样囊性癌。平均手术时间为 3.2 分钟(范围,1.3-8.7 分钟)。整块和完全切除率分别为 100%。随访期间无复发。
UW-EMR 是治疗嵌入黏膜下层的上消化道 SET 的一种安全有效的方法。需要进一步的研究来比较其他内镜切除技术。